Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (1H-indol-7-yl)-(pyrimidin-2-ylamino)methanone derivatives and related compounds as IGF-R1 inhibitors for the treatment of cancer

(1H-indol-7-yl)-(pyrimidin-2-ylamino)methanone derivatives and related compounds as IGF-R1 inhibitors for the treatment of cancer

US Patent 8114882 · Granted Feb 14, 2012

Estimated economic value: $79,195,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for manufacturing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-ca2025
Disubstituted alkyne derivatives2025
Cyclic amides as MetAP-2 inhibitors2018
Pyrrolidinone derivatives as MetAP-2 inhibitors2018
Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced 2016
Pyridazinone derivatives2016
Pyridazinone derivatives2016
Bicyclic heteroaromatic compounds2016
1-H-pyrrolo[2,3-b]pyridine derivatives2016
2-(heterocyclylbenzyl)pyridazinone derivatives2015
Substituted azaheterocycles for the treatment of cancer2015
Pyrimidinyl pyridazinone derivatives2015